Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.
Woreta TA, Van Natta ML, Lazo M, Krishnan A, Neuschwander-Tetri BA, Loomba R, Mae Diehl A, Abdelmalek MF, Chalasani N, Gawrieh S, Dasarathy S, Vuppalanchi R, Siddiqui MS, Kowdley KV, McCullough A, Terrault NA, Behling C, Kleiner DE, Fishbein M, Hertel P, Wilson LA, Mitchell EP, Miriel LA, Clark JM, Tonascia J, Sanyal AJ; NASH Clinical Research Network.
Woreta TA, et al.
PLoS One. 2022 Apr 15;17(4):e0266859. doi: 10.1371/journal.pone.0266859. eCollection 2022.
PLoS One. 2022.
PMID: 35427375
Free PMC article.
The new FAST score, a combination of FibroScan parameters liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) and aspartate aminotransferase (AST), has shown good diagnostic accuracy for at-risk NASH (area-under-the-Receiver-Operating-Characteristi …
The new FAST score, a combination of FibroScan parameters liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) and a …